1. Home
  2. OCG vs DCOY Comparison

OCG vs DCOY Comparison

Compare OCG & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oriental Culture Holding LTD

OCG

Oriental Culture Holding LTD

N/A

Current Price

$1.59

Market Cap

3.3M

ML Signal

N/A

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$2.75

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCG
DCOY
Founded
2018
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.2M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
OCG
DCOY
Price
$1.59
$2.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
62.8K
18.8K
Earning Date
05-14-2026
05-16-2026
Dividend Yield
8.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.53
52 Week High
$19.29
$13.51

Technical Indicators

Market Signals
Indicator
OCG
DCOY
Relative Strength Index (RSI) 42.08 31.14
Support Level $1.45 $0.61
Resistance Level $1.88 $3.29
Average True Range (ATR) 0.12 0.20
MACD -0.01 0.04
Stochastic Oscillator 2.50 12.50

Price Performance

Historical Comparison
OCG
DCOY

About OCG Oriental Culture Holding LTD

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance services to customers. The company operates through one segment, namely, e-commerce of artwork trading. The company generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: